Forum Alert: Harvard Bioscience Inc. Presentation at Informed Investors Biotechnology & Pharmaceuticals Stocks Forum at the Princeton Club in NYC on Wednesday, June 23, 2004, 11:30 am ET
HOLLISTON, Mass., June 21 /PRNewswire/ -- David Green, President of Harvard Bioscience Inc. (Nasdaq: HBIO), will present at the following forum:
What: Informed Investors Biotechnology & Pharmaceuticals Stocks Forum When: June 23, 2004 @ 11:30 AM Eastern Time Where: The Princeton Club of New York, 15 West 43rd St. (Between 5th and 6th Avenues) New York, NY 10036 How: To attend live event, pre-registration is necessary. To register contact Cary Loeser, email@example.com, 804-327-3407 or call Customer Service at 888-301-6618.
If you are unable to attend the live event, the forum will be available via webcast at http://www.informedinvestors.com/CustomEvent/85117/index.asp?ForumID=85117.
Harvard Bioscience Inc. is a global developer, manufacturer and marketer of a range of specialized products, primarily scientific instruments, used to accelerate drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide.
FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, firstname.lastname@example.org
Web site: http://www.informedinvestors.com
SOURCE Harvard Bioscience Inc.
CONTACT: Cary Loeser, Informed Investors, 1-804-327-3407,
email@example.com, for Harvard Bioscience Inc.
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.